2013•Leukemia & lymphoma/Leukemia and lymphomaOpen access

Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis

Monica Maccaferri, Giovanna Leonardi, Roberto Marasca, Elisabetta Colaci, Ambra Paolini, Francesco Soci, Fabio Forghieri, Leonardo Potenza, Franco Narni, Mario Luppi

Open full text 11 citations

Abstract

Myelofibrosis (MF) is a chronic myeloproliferative disease that occurs de novo or secondary to polycythemia vera or essential thrombocythemia, often characterized by splenomegaly, bone marrow fibro...

About this research paper

What this paper is about

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Myelofibrosis, Ruxolitinib, Extramedullary hematopoiesis, Medicine, Haematopoiesis, Hematologic Neoplasms, Cancer research, Internal medicine